45.19
price down icon0.04%   -0.02
after-market After Hours: 45.22 0.03 +0.07%
loading

Amphastar Pharmaceuticals Inc Stock (AMPH) Latest News

pulisher
04:27 AM

Why Amphastar Pharmaceuticals (AMPH) Is One of the Most Profitable Pharmaceutical Stocks Right Now? - Yahoo Finance

04:27 AM
pulisher
Nov 28, 2024

Here's Why Amphastar Pharmaceuticals (NASDAQ:AMPH) Has Caught The Eye Of Investors - Simply Wall St

Nov 28, 2024
pulisher
Nov 28, 2024

Financial Review: UroGen Pharma (NASDAQ:URGN) and Amphastar Pharmaceuticals (NASDAQ:AMPH) - Defense World

Nov 28, 2024
pulisher
Nov 26, 2024

Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference - AccessWire

Nov 26, 2024
pulisher
Nov 26, 2024

Amphastar Continues To Push Proprietary Portfolio With Focus On Baqsimi - Citeline

Nov 26, 2024
pulisher
Nov 26, 2024

Algert Global LLC Purchases New Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Nov 26, 2024
pulisher
Nov 25, 2024

Amphastar initiated with an Equal Weight at Wells Fargo - MSN

Nov 25, 2024
pulisher
Nov 24, 2024

Connor Clark & Lunn Investment Management Ltd. Sells 20,448 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Nov 24, 2024
pulisher
Nov 24, 2024

Segall Bryant & Hamill LLC Buys New Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Nov 24, 2024
pulisher
Nov 24, 2024

Amphastar Pharmaceuticals (NASDAQ:AMPH) Coverage Initiated at Wells Fargo & Company - Defense World

Nov 24, 2024
pulisher
Nov 23, 2024

Wells Fargo initiates Amphastar stock with Overweight, sees upside with new product cycle By Investing.com - Investing.com South Africa

Nov 23, 2024
pulisher
Nov 23, 2024

GSA Capital Partners LLP Invests $303,000 in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Nov 23, 2024
pulisher
Nov 23, 2024

Wells Fargo Initiates Coverage of Amphastar Pharmaceuticals (AMPH) with Overweight Recommendation - MSN

Nov 23, 2024
pulisher
Nov 22, 2024

Wells Fargo initiates Amphastar stock with Overweight, sees upside with new product cycle - Investing.com

Nov 22, 2024
pulisher
Nov 21, 2024

Tranche Update on Amphastar Pharmaceuticals, Inc.'s Equity Buyback Plan announced on November 8, 2016. - Marketscreener.com

Nov 21, 2024
pulisher
Nov 21, 2024

Victory Capital Management Inc. Grows Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Nov 21, 2024
pulisher
Nov 21, 2024

Victory Capital Management Inc. Has $10.61 Million Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Nov 21, 2024
pulisher
Nov 19, 2024

Injectables Contraceptives Market with Promising Opportunity - openPR

Nov 19, 2024
pulisher
Nov 19, 2024

Principal Financial Group Inc. Has $9.80 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Principal Financial Group Inc. Cuts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Nov 19, 2024
pulisher
Nov 16, 2024

16,169 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Purchased by Los Angeles Capital Management LLC - MarketBeat

Nov 16, 2024
pulisher
Nov 14, 2024

Amphastar Pharmaceuticals executive sells $336,929 in stock - Investing.com India

Nov 14, 2024
pulisher
Nov 13, 2024

Amphastar Pharmaceuticals director Richard Prins sells $243,985 in stock - Investing.com India

Nov 13, 2024
pulisher
Nov 13, 2024

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference - AccessWire

Nov 13, 2024
pulisher
Nov 13, 2024

Amphastar Pharmaceuticals to Present at Jefferies London Healthcare Conference | AMPH Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 13, 2024

Amphastar Pharmaceuticals Inc (AMPH) Stock Price Down 3.5% on No - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by US Bancorp DE - Defense World

Nov 13, 2024
pulisher
Nov 13, 2024

FDA Approves Amphastar's New Epinephrine Drug, Boosting Market Growth - openPR

Nov 13, 2024
pulisher
Nov 11, 2024

Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings - MSN

Nov 11, 2024
pulisher
Nov 11, 2024

Amphastar Pharmaceuticals Reports Strong Q3 2024 Results - TipRanks

Nov 11, 2024
pulisher
Nov 10, 2024

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by New York State Teachers Retirement System - Defense World

Nov 10, 2024
pulisher
Nov 09, 2024

Insider Selling: Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) EVP Sells 5,214 Shares of Stock - MarketBeat

Nov 09, 2024
pulisher
Nov 09, 2024

William J. Peters Sells 7,426 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock - MarketBeat

Nov 09, 2024
pulisher
Nov 09, 2024

Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - Simply Wall St

Nov 09, 2024
pulisher
Nov 08, 2024

Amphastar Pharmaceuticals executive sells $271,388 in stock By Investing.com - Investing.com Nigeria

Nov 08, 2024
pulisher
Nov 08, 2024

Amphastar Pharmaceuticals executive sells $271,388 in stock - Investing.com

Nov 08, 2024
pulisher
Nov 08, 2024

Amphastar CFO William J. Peters sells shares for $386,523 - Investing.com

Nov 08, 2024
pulisher
Nov 08, 2024

Amphastar CFO William J. Peters sells shares for $386,523 By Investing.com - Investing.com Canada

Nov 08, 2024
pulisher
Nov 08, 2024

Amphastar Pharmaceuticals Inc (AMPH) Shares Up 3.62% on Nov 8 - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 08, 2024
pulisher
Nov 08, 2024

Amphastar Pharmaceuticals Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 08, 2024
pulisher
Nov 07, 2024

Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap DownTime to Sell? - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Amphastar: Q3 Earnings Snapshot - Houston Chronicle

Nov 07, 2024
pulisher
Nov 06, 2024

Amphastar Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 06, 2024
pulisher
Nov 06, 2024

Amphastar Pharmaceuticals (AMPH) Lags Q3 Earnings and Revenue Estimates - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2024 - AccessWire

Nov 06, 2024
pulisher
Nov 06, 2024

Amphastar Q3 Revenue Hits $191.2M; BAQSIMI Sales Shine as Board Boosts Buyback Program | AMPH Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 06, 2024

Hyaluronidase Market Set for Rapid Expansion (2024-2031): - openPR

Nov 06, 2024
pulisher
Nov 05, 2024

Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Pre - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Mirae Asset Global Investments Co. Ltd. - Defense World

Nov 05, 2024
pulisher
Nov 05, 2024

Amphastar Pharmaceuticals Inc (AMPH) Q3 2024 Earnings Report Preview: What to Expect - Yahoo Finance

Nov 05, 2024
pulisher
Nov 03, 2024

Amphastar Pharmaceuticals (NASDAQ:AMPH) Rating Lowered to “Hold” at StockNews.com - Defense World

Nov 03, 2024
$89.27
price down icon 1.11%
$13.21
price up icon 0.61%
$85.65
price down icon 1.09%
$61.11
price up icon 0.18%
$126.75
price up icon 0.13%
$13.09
price down icon 0.98%
Cap:     |  Volume (24h):